Hepatology Communications

🚨GI/Hep Fellowships start next week‼️ @HepCommJournal has the 📑 you need to thrive 💫 #GIHepFellowshipBootcamp First up, you get a consult for a #LiverMass, ✅ out this review about benign liver masses❕ 📍Hemangiomas 📍FNH 📍Hepatic Adenomas 📍Cysts journals.lww.com/hepcomm/fullte…

🔥 HOT TOPIC 📘 @HepCommJournal Blood-based biomarker screening represents a transformative advance in liver cancer surveillance, and this #HCC Early Detection Strategy (HEDS) study tackles the crucial challenges of optimizing test thresholds and interpreting how changes over time affect early detection performance. Read the full study here: bit.ly/4bBmDFX

Co-Editors @ebtapper and Carmen Chak-Lui Wong share exciting science from the February issue of @HepCommJournal including studies on the reproductive hormones and #MASLD, increases in patient quality of life on #Resmetirom, the role of cGAS beyond viral DNA sensing, new #HCC research, and much more. #LiverTwitter Watch below and view the latest issue here: bit.ly/4sf5gBm youtube.com/watch?v=WYDtqX…

The rate, predictors, and outcomes of recompensation in MASH cirrhosis @HepCommJournal journals.lww.com/hepcomm/fullte…

📑 Prevalence and outcomes of steatotic liver disease subtypes in older adults❕ journals.lww.com/hepcomm/fullte…

📑 Electronic decision aids enhance management of primary care patients with steatotic liver disease‼️ ➡️ Automated, FIB-4–based guidance   ➡️ Guideline adherence ⬆️ from 30% to 46%    One click closer to improved #MASLD care❕ journals.lww.com/hepcomm/fullte…

📑 Plasma proteome correlations with liver stiffness in pediatric cholestasis implicate epithelial to mesenchymal transition‼️ journals.lww.com/hepcomm/fullte…

📑 High biochemical remission rates in patients with #PBC treated with “triple” anticholestatic therapy❗️ journals.lww.com/hepcomm/fullte…

This #WomensHistoryMonth, AASLD is celebrating the women in editorial leadership. From the first woman to serve as Co-Editor-in-Chief of @HEP_Journal to the Co-Editor-in-Chief of @HepCommJournal, women's voices are shaping liver science and clinical knowledge. Featuring perspectives from Laura E. Nagy, PhD, FAASLD and Carmen Chak-Lui Wong, PhD.

📑 Awareness of #MASLD in 4 major cities in the United States 🇺🇸 is LOW‼️ journals.lww.com/hepcomm/fullte…

📑 Pregnancy and #liver-related outcomes after #alcohol-associated hepatitis: A global multicenter study❕ #LiverX #OpenAccess journals.lww.com/hepcomm/fullte…

📑 Early experience with resmetirom to treat #MASH with fibrosis in a real-world setting‼️ #OpenAccess @neel_ravela journals.lww.com/hepcomm/fullte…

🔥 HOT TOPIC 💻 @HepCommJournal A new systematic review of 68 randomized trials suggests albumin infusion in cirrhosis may reduce mortality and complications, while highlighting the need for more rigorous evidence to fully understand its benefits and risks. Read the full study here: bit.ly/4qV49p9

📑 Culturally tailored #steatotic liver disease management: Latino and Asian community partner perspectives and recommendations‼️ journals.lww.com/hepcomm/fullte…

📑 Diet composition impacts the natural history of steatotic liver disease❕ Foods/nutrients associated with the #MediterraneanDiet (☕️🥦🥬 🍠🥜🫘🍗) are associated with reduced #MASLD fibrosis progression in the Million Veteran Cohort Program ‼️ journals.lww.com/hepcomm/fullte…

📑 Educational, financial, logistical, emotional, and social needs among patients with #HCC❕ Patients with #HCC face 5️⃣ 🔑 navigation challenges: 1️⃣Educational, 2️⃣Financial, 3️⃣Logistical, 4️⃣Emotional, and 5️⃣Social journals.lww.com/hepcomm/fullte…

📑 An optimized peritonitis-induced #ACLF model that reproduces the full spectrum of extrahepatic organ failures in mice 🐁 journals.lww.com/hepcomm/fullte…

📑 VLDL lipidomics reveals hepatocellular lipidome changes in #MASLD ‼️ journals.lww.com/hepcomm/fullte…

📑 Treatment of #AUD in alcohol-associated liver disease: A meta-analysis❕ ⬆️ 🍻 Abstinence ⬇️ Readmissions 🏥 and decompensations journals.lww.com/hepcomm/fullte…

📑 CRISPR-mediated proximity labeling unveils ABHD14B as a host factor to regulate HBV cccDNA transcriptional activity‼️ journals.lww.com/hepcomm/fullte…

📑 A phase 2 trial of short-term intravenous N-acetylcysteine in biliary atresia after #Kasai portoenterostomy❕ journals.lww.com/hepcomm/fullte…